Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: Safety Study of Levocetirizine and Fexofenadine [Phase 4]

View source ↗

Summary

Phase 4 safety study investigating levocetirizine and fexofenadine in pruritus and chronic urticaria completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine (fexofenadine)
  • Levocetirizine (Levocetirizine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Pruritus, Chronic Urticaria | Phase 4 | Status: COMPLETED | Results posted: 2019-10-04